Anesthesia
CO2 absorbents refer to medical grade chemicals. They are used in closed
breathing environments to remove carbon dioxide (CO2) from breathing gases. CO2
absorbent is proposed for use in anesthesia circle systems for the purpose of
removing respired carbon dioxide. The absorption of CO2 is mandatory in closed &
semi-closed circle breathing systems. The elimination of CO2 from exhaled gases
is accomplished through chemical neutralization in transparent containers
containing absorbent granules. The ideal CO2 absorbent have low airflow
resistance, high efficiency, no toxicity or reactions with inhalation
anesthetics, and low cost. Effective Co2 absorption prevents CO2 rebreathing &
development of hypercapnia.
According
to study, “World
Anesthesia CO2 Absorbent Market Research Report 2024(Covering USA, Europe,
China, Japan, SEA and India)” the key companies operating in
the world anesthesia CO2 absorbent market are CareFusion (Becton Dickinson and
Co.), Allied Healthcare Products, Drager Medical GmbH, Micropore, Armstrong
Medical, Thomasnet, Intersurgical, King Pharmaceuticals, Molecular Products, Smiths
Medical, GE Healthcare, SCL International, Medisize. In order to improve
market position, the key companies are focusing on adopting the strategies for
instance product innovations, recent developments, mergers & acquisitions,
joint venture, collaborations, and partnership.
Based
on type, anesthesia CO2 absorbent market
is segmented into premium anesthesia CO2 absorbent and traditional anesthesia
CO2 absorbent. Based on product type, market is segmented into medisorb, sodalime,
amsorb, dragersorb, litholyme and others. Amsorb is estimated to witness the
fastest growth over the forecast period due to rise in demand for absorbents
free from presence of KOH and simplicity in exhaustion indication. Based on
form, market is segmented into powered form (bounded by polymer) and granular
form. In addition, based on end-use, market is segmented into clinics and
hospitals.
The
anesthesia CO2 absorbent market is driven by growth in the number of people
undergoing surgical procedures, followed by increase in presence of
well-developed healthcare sector, rise in supportive government initiatives, increase
in number of surgeries, surge in occurrence of accidents
& chronic ailments (neurological conditions, respiratory disorders, cardiac
arrest, and diabetes), increase in usage of regional anesthesia, and
rise in percentage of geriatric population. However, stringent government
regulations and medical safety concerns related to an improper administration
of anesthesia may impact the market. Moreover, worldwide guidelines &
safety parameters pertaining the use of anesthesia and increase in investment
on developing newer CO2 absorbing formulations are key opportunities for
market.
The
Anesthesia Patient Safety Foundation and Centers for Disease
Control and Prevention (CDC) are government institutes which provide a better
understanding of inevitable anesthetic injuries, encourage programs that will
decrease the number of anesthetic injuries, and promote national &
international communication of information or ideas about the causes & prevention of anesthetic injuries.
Based
on geography, USA country holds major share, followed by Europe in anesthesia
CO2 absorbent market owing to escalation in the number of surgeries being
performed, endeavors of healthcare agencies to promote medical tourism and favorable
government regulations in the country. China, India and Japan countries are
expected to witness higher growth rate due to considerable increase in per
capita health expenditure and rapid development of healthcare sector over the
forecast period. The market will register 8.2% CAGR in terms of proceeds, the global
market size will reach US $82 million by 2024, from US $51 million in 2019.
For more information,
refer to below link:-
Contact
Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
